In JAMA Ophthalmology, authors reported the findings from a matched cohort study using data from a centralized data registry of patients evaluated by neuro-ophthalmologists at one academic institution
A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
There may be differing opinions or unique experiences
Step-by-Step: Using a Pre-filled Pen For those using a pen-style delivery system, the process is streamlined but still requires careful attention to the click or dose window
Semaglutide works for weight loss in non-diabetics
They mimic the naturally occurring hormone GLP-1 (glucagon-like peptide-1), which has three main effects: Slows food movement through your stomach, helping you feel fuller for longer Communicates with your brains appetite centre (the hypothalamus) to reduce hunger Improves blood sugar control by enhancing insulin function The natural GLP-1 hormone lasts only minutes before being cleared